Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kavanagh

Showing results (671-680 of 764) with videos related to

Pageof 77
Sort By:
Cancer Genetics and Cytogenetics|November 1, 1995
p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumorJ H Lee, Y S Kang, S Y Park, et al.
Nanotoxicology|July 2, 2014
Amphiphilic polymer-coated CdSe/ZnS quantum dots induce pro-inflammatory cytokine expression in mouse lung epithelial cells and macrophagesVivian Lee, Ryan S McMahan, Xiaoge Hu, et al.
Free Radical Biology & Medicine|July 25, 2012
Glutathione (GSH) and the GSH synthesis gene Gclm modulate vascular reactivity in miceChad S Weldy, Ian P Luttrell, Collin C White, et al.
Nanotoxicology|January 24, 2012
Heme oxygenase expression as a biomarker of exposure to amphiphilic polymer-coated CdSe/ZnS quantum dotsLisa A McConnachie, Collin C White, Dianne Botta, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.
Gynecologic Oncology|December 7, 2002
Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?Charlotte C Sun, Diane C Bodurka, Michele L Donato, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 12, 2001
Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years laterC F Verschraegen, M Benjapibal, W Supakarapongkul, et al.
Journal of the National Cancer Institute|November 20, 1991
Clinical pharmacology, metabolism, and tissue distribution of 90Y-labeled monoclonal antibody B72.3 after intraperitoneal administrationM G Rosenblum, J J Kavanagh, T W Burke, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 20, 2020
Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains UnidentifiedDaniel H Breysse, Ryan M Boone, Cameron M Long, et al.
Atherosclerosis|August 12, 2008
Homocysteine stimulates antioxidant response element-mediated expression of glutamate-cysteine ligase in mouse macrophagesFlorian Bea, Francesca N Hudson, Haley Neff-Laford, et al.
Pageof 77

Showing results (671-680 of 764) with videos related to

Sort By:
Pageof 77
Cancer Genetics and Cytogenetics|November 1, 1995
p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumorJ H Lee, Y S Kang, S Y Park, et al.
Nanotoxicology|July 2, 2014
Amphiphilic polymer-coated CdSe/ZnS quantum dots induce pro-inflammatory cytokine expression in mouse lung epithelial cells and macrophagesVivian Lee, Ryan S McMahan, Xiaoge Hu, et al.
Free Radical Biology & Medicine|July 25, 2012
Glutathione (GSH) and the GSH synthesis gene Gclm modulate vascular reactivity in miceChad S Weldy, Ian P Luttrell, Collin C White, et al.
Nanotoxicology|January 24, 2012
Heme oxygenase expression as a biomarker of exposure to amphiphilic polymer-coated CdSe/ZnS quantum dotsLisa A McConnachie, Collin C White, Dianne Botta, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.
Gynecologic Oncology|December 7, 2002
Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?Charlotte C Sun, Diane C Bodurka, Michele L Donato, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 12, 2001
Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years laterC F Verschraegen, M Benjapibal, W Supakarapongkul, et al.
Journal of the National Cancer Institute|November 20, 1991
Clinical pharmacology, metabolism, and tissue distribution of 90Y-labeled monoclonal antibody B72.3 after intraperitoneal administrationM G Rosenblum, J J Kavanagh, T W Burke, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 20, 2020
Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains UnidentifiedDaniel H Breysse, Ryan M Boone, Cameron M Long, et al.
Atherosclerosis|August 12, 2008
Homocysteine stimulates antioxidant response element-mediated expression of glutamate-cysteine ligase in mouse macrophagesFlorian Bea, Francesca N Hudson, Haley Neff-Laford, et al.
Pageof 77